UK MHRA: Navigating Nuances in Clinical Trial Applications
The UK Medicines and Healthcare products Regulatory Agency (MHRA) receives approximability 1000 clinical trial authorization (CTA) applications a year. These are for investigational medicinal products of which >95% are approved. However, >50% still need additional information to be submitted in order to get approved. The majority of the requests for additional information, including “grounds for […]
UK MHRA: Navigating Nuances in Clinical Trial Applications Read More »